+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cervical Dysplasia Market by Diagnostics Type (Biopsy, Colposcopy, HPV Test), Treatment Type (Chemotherapy, Radiation Therapy, Surgery), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5336906
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cervical Dysplasia Market size was estimated at USD 754.39 million in 2023, USD 806.03 million in 2024, and is expected to grow at a CAGR of 6.93% to reach USD 1,206.52 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cervical Dysplasia Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cervical Dysplasia Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cervical Dysplasia Market, highlighting leading vendors and their innovative profiles. These include Asieris Pharmaceuticals, ASKA Pharmaceutical Co., Ltd., Becton, Dickinson, and Company, BetterLife Pharma Inc., Bristol-Myers Squibb Company, Cardinal Health Inc., CooperSurgical Inc, DYSIS Medical Ltd., F. Hoffmann La-Roche Ltd, GlaxoSmithKline PLC, Guided Therapeutics, Inc., Helix BioPharma Corp., Hologic, Inc., Karl Kaps GmbH & Co. KG, OncoHealth Corp, PDS Biotechnology company, Polaris Pharmaceuticals, Inc., Qiagen N.V., Quest Diagnostics, Inc., and ViciniVax B.V.

Market Segmentation & Coverage

This research report categorizes the Cervical Dysplasia Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Diagnostics Type
    • Biopsy
    • Colposcopy
    • HPV Test
    • Pap Smear Test
  • Treatment Type
    • Chemotherapy
    • Radiation Therapy
    • Surgery
    • Therapeutic HPV Vaccines
  • End-User
    • Ambulatory Surgery Centers
    • Diagnostic Centers
    • Hospitals
    • Research & Academic Institutes
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Cervical Dysplasia Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cervical Dysplasia Market?
  3. What are the technology trends and regulatory frameworks in the Cervical Dysplasia Market?
  4. What is the market share of the leading vendors in the Cervical Dysplasia Market?
  5. Which modes and strategic moves are suitable for entering the Cervical Dysplasia Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cervical Dysplasia Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of cervical cancer worldwide
5.1.1.2. Rising initiatives by the government to enhance the screening of cervical dysplasia
5.1.1.3. Inclination of patients towards minimal invasive surgeries
5.1.2. Restraints
5.1.2.1. High cost of diagnostic devices and treatment
5.1.3. Opportunities
5.1.3.1. Technological advancements in screening devices and other supporting equipment
5.1.3.2. Emergence of cervical screening programs
5.1.4. Challenges
5.1.4.1. Lack of awareness in developing countries and low diagnostic device approval rate
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cervical Dysplasia Market, by Diagnostics Type
6.1. Introduction
6.2. Biopsy
6.3. Colposcopy
6.4. HPV Test
6.5. Pap Smear Test
7. Cervical Dysplasia Market, by Treatment Type
7.1. Introduction
7.2. Chemotherapy
7.3. Radiation Therapy
7.4. Surgery
7.5. Therapeutic HPV Vaccines
8. Cervical Dysplasia Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Diagnostic Centers
8.4. Hospitals
8.5. Research & Academic Institutes
8.6. Specialty Clinics
9. Americas Cervical Dysplasia Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cervical Dysplasia Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cervical Dysplasia Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Asieris Pharmaceuticals
13.1.2. ASKA Pharmaceutical Co., Ltd.
13.1.3. Becton, Dickinson, and Company
13.1.4. BetterLife Pharma Inc.
13.1.5. Bristol-Myers Squibb Company
13.1.6. Cardinal Health Inc.
13.1.7. CooperSurgical Inc
13.1.8. DYSIS Medical Ltd.
13.1.9. F. Hoffmann La-Roche Ltd
13.1.10. GlaxoSmithKline PLC
13.1.11. Guided Therapeutics, Inc.
13.1.12. Helix BioPharma Corp.
13.1.13. Hologic, Inc.
13.1.14. Karl Kaps GmbH & Co. KG
13.1.15. OncoHealth Corp
13.1.16. PDS Biotechnology company
13.1.17. Polaris Pharmaceuticals, Inc.
13.1.18. Qiagen N.V.
13.1.19. Quest Diagnostics, Inc.
13.1.20. ViciniVax B.V.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. CERVICAL DYSPLASIA MARKET RESEARCH PROCESS
FIGURE 2. CERVICAL DYSPLASIA MARKET SIZE, 2023 VS 2030
FIGURE 3. CERVICAL DYSPLASIA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CERVICAL DYSPLASIA MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CERVICAL DYSPLASIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CERVICAL DYSPLASIA MARKET DYNAMICS
FIGURE 7. CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2023 VS 2030 (%)
FIGURE 8. CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 10. CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CERVICAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CERVICAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CERVICAL DYSPLASIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CERVICAL DYSPLASIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CERVICAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CERVICAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CERVICAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CERVICAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CERVICAL DYSPLASIA MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. CERVICAL DYSPLASIA MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. CERVICAL DYSPLASIA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CERVICAL DYSPLASIA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CERVICAL DYSPLASIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 6. CERVICAL DYSPLASIA MARKET SIZE, BY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CERVICAL DYSPLASIA MARKET SIZE, BY COLPOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CERVICAL DYSPLASIA MARKET SIZE, BY HPV TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CERVICAL DYSPLASIA MARKET SIZE, BY PAP SMEAR TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 11. CERVICAL DYSPLASIA MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CERVICAL DYSPLASIA MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CERVICAL DYSPLASIA MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CERVICAL DYSPLASIA MARKET SIZE, BY THERAPEUTIC HPV VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16. CERVICAL DYSPLASIA MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CERVICAL DYSPLASIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CERVICAL DYSPLASIA MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CERVICAL DYSPLASIA MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS CERVICAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. CANADA CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. MEXICO CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES CERVICAL DYSPLASIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC CERVICAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. CHINA CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 49. CHINA CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 50. CHINA CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. INDIA CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDIA CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDIA CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. JAPAN CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 59. JAPAN CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. THAILAND CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. THAILAND CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA CERVICAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 87. DENMARK CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. EGYPT CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. EGYPT CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. FINLAND CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 93. FINLAND CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. FRANCE CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 96. FRANCE CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. GERMANY CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. ITALY CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 104. ITALY CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 105. ITALY CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. NORWAY CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 114. NORWAY CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. POLAND CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 116. POLAND CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. POLAND CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. QATAR CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. QATAR CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SPAIN CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 132. SPAIN CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. TURKEY CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. TURKEY CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM CERVICAL DYSPLASIA MARKET SIZE, BY DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM CERVICAL DYSPLASIA MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM CERVICAL DYSPLASIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. CERVICAL DYSPLASIA MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 149. CERVICAL DYSPLASIA MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. CERVICAL DYSPLASIA MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Asieris Pharmaceuticals
  • ASKA Pharmaceutical Co., Ltd.
  • Becton, Dickinson, and Company
  • BetterLife Pharma Inc.
  • Bristol-Myers Squibb Company
  • Cardinal Health Inc.
  • CooperSurgical Inc
  • DYSIS Medical Ltd.
  • F. Hoffmann La-Roche Ltd
  • GlaxoSmithKline PLC
  • Guided Therapeutics, Inc.
  • Helix BioPharma Corp.
  • Hologic, Inc.
  • Karl Kaps GmbH & Co. KG
  • OncoHealth Corp
  • PDS Biotechnology company
  • Polaris Pharmaceuticals, Inc.
  • Qiagen N.V.
  • Quest Diagnostics, Inc.
  • ViciniVax B.V.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 806.03 Million
Forecasted Market Value ( USD ) by 2030 $ 1206.52 Million
Compound Annual Growth Rate6.9%
Regions CoveredGlobal

Related Topics

Related Reports

Cervical Dysplasia Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Cervical Dysplasia Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Cervical Dysplasia Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Cervical Dysplasia Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
Cervical Dysplasia Diagnostics - Global Strategic Business Report - Product Image

Cervical Dysplasia Diagnostics - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Cervical Dysplasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Cervical Dysplasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 138 Pages
  • Global
From
Cervical Dysplasia Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Cervical Dysplasia Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 105 Pages
  • Global
From

About the Cervical Dysplasia Market

Cervical Dysplasia is a condition in which abnormal cells grow on the surface of the cervix, the lower part of the uterus. It is a common condition in women of reproductive age and is usually caused by the human papillomavirus (HPV). Cervical Dysplasia can be detected through a Pap test, which is a routine screening test for women. If left untreated, Cervical Dysplasia can lead to cervical cancer. Treatment options for Cervical Dysplasia include cryotherapy, laser therapy, and loop electrosurgical excision procedure (LEEP). There are several companies in the Cervical Dysplasia market, including AbbVie, Merck, and GlaxoSmithKline. These companies offer treatments for Cervical Dysplasia, such as vaccines and medications. Other companies in the market include Roche, Sanofi, and Pfizer. These companies offer diagnostic tests and treatments for Cervical Dysplasia. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.